Pathogenic Advances and Therapeutic Perspectives for Eosinophilic Inflammation
With the recent approval of the first eosinophil-depleting therapeutic agents targeting the IL-5 pathway for treatment of severe eosinophilic asthma, eosinophils and eosinophilic disorders are in the limelight. Indeed, setbacks during clinical development of these compounds have revealed how much re...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Online |
| Langue: | anglais |
| Publié: |
Frontiers Media SA
2021
|
| Sujets: | |
| Accès en ligne: | 32022 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|
Soyez le premier à ajouter un commentaire!